Companies

MindMend

Mentioned in 1 analyzed podcast episode across 1 show

Episode Mentions

Bloomberg Intelligence

Bloomberg Intelligence · Jul 16, 2026

Lilly Strikes $3.8 Billion Deal for Psychedelic Drugmaker

Psychedelic drug development company in treatment-resistant depression market

Psychedelic Drug Development and RegulationEli Lilly M&A Strategy and Contingent Value RightsPCSK9 Inhibitors and Cholesterol Management
View Analysis